Barbara S Slusher Selected Research

Radiotherapy

6/2020	Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.
1/2009	In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara S Slusher Research Topics

Disease

47	Neoplasms (Cancer) 05/2024 - 06/2004
12	Infections 11/2023 - 06/2013
12	Neuralgia (Stump Neuralgia) 01/2017 - 02/2002
11	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 10/2005
10	Nervous System Diseases (Neurological Disorders) 01/2024 - 05/2010
10	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 04/2011
10	Inflammation (Inflammations) 10/2023 - 10/2003
10	Cognitive Dysfunction 07/2023 - 12/2012
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2011
8	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 06/2004
8	Vomiting 12/2015 - 09/2006
8	Nausea 12/2015 - 09/2006
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 08/2016
6	Neuroinflammatory Diseases 01/2023 - 06/2014
6	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2009
6	Schizophrenia (Dementia Praecox) 05/2016 - 06/2005
5	Pain (Aches) 01/2022 - 12/2012
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 06/2003
5	Neurocognitive Disorders (Clerambault Syndrome) 09/2021 - 06/2013
5	Glioma (Gliomas) 01/2021 - 01/2009
5	Hyperalgesia 12/2018 - 02/2002
4	Substance-Related Disorders (Drug Abuse) 01/2023 - 07/2015
4	Medulloblastoma 03/2022 - 10/2019
4	Breast Neoplasms (Breast Cancer) 02/2021 - 06/2011
4	Opioid-Related Disorders (Opiate Addiction) 01/2019 - 03/2003
4	Multiple Sclerosis 01/2015 - 12/2012
3	Colitis 01/2023 - 08/2016
3	Hypoxia (Hypoxemia) 01/2023 - 01/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2016
3	Carcinogenesis 01/2022 - 06/2015
3	Brain Injuries (Brain Injury) 12/2021 - 10/2005
3	Wounds and Injuries (Trauma) 01/2018 - 12/2012
3	Encephalomyelitis (Myeloencephalitis) 01/2017 - 04/2015
3	Dementia (Dementias) 01/2014 - 09/2009
2	Neurofibrosarcoma (MPNST) 12/2023 - 01/2020
2	Tuberculosis (Tuberculoses) 11/2023 - 02/2023
2	Neoplasm Metastasis (Metastasis) 12/2022 - 10/2005
2	HIV Infections (HIV Infection) 08/2022 - 06/2013
2	Virus Diseases (Viral Diseases) 01/2022 - 04/2015
2	Canavan Disease (Leukodystrophy, Spongiform) 01/2022 - 01/2021
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022 - 10/2019
2	Muscle Weakness 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

38	Glutamine (L-Glutamine)FDA Link 05/2024 - 11/2010
32	Glutamic Acid (Glutamate)FDA Link 01/2023 - 02/2002
25	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 01/2023 - 02/2002
21	ProdrugsIBA 05/2024 - 09/2016
13	DiazooxonorleucineIBA 11/2023 - 04/2015
12	GlutaminaseIBA 12/2022 - 11/2010
10	EnzymesIBA 01/2023 - 12/2005
8	AcidsIBA 10/2021 - 02/2002
7	JHU083IBA 05/2024 - 01/2019
7	AntigensIBA 04/2024 - 06/2004
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2011
7	Palonosetron (Aloxi)FDA Link 12/2015 - 01/2010
6	LigandsIBA 01/2023 - 11/2010
6	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 12/2021 - 01/2015
5	CeramidesIBA 12/2023 - 05/2019
5	metabotropic glutamate receptor 3 (mGluR3)IBA 10/2023 - 10/2003
5	Dopamine D3 ReceptorsIBA 10/2019 - 07/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 05/2010
5	eribulin FDA Link 01/2018 - 06/2011
5	Analgesics (Analgesic Drugs)IBA 01/2017 - 02/2002
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2014
4	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2019
4	2-(phosphonomethyl)pentanedioic acidIBA 10/2017 - 09/2002
4	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 05/2010
4	Serotonin (5 Hydroxytryptamine)IBA 01/2014 - 06/2005
4	Substance PIBA 08/2012 - 09/2006
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2012
3	JHU395IBA 12/2023 - 01/2020
3	NucleotidesIBA 12/2023 - 02/2021
3	purineIBA 12/2023 - 01/2020
3	EstersIBA 11/2023 - 01/2017
3	AmidesIBA 11/2023 - 02/2021
3	Lysine (L-Lysine)FDA Link 12/2022 - 12/2012
3	Amino Acids FDA Link 03/2022 - 01/2016
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 08/2003
3	isospaglumic acid (NAAGA)IBA 01/2021 - 02/2002
3	Opioid Analgesics (Opioids)IBA 01/2019 - 12/2005
3	N-Methylaspartate (NMDA)IBA 01/2016 - 09/2002
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2014 - 06/2012
3	TachykininsIBA 01/2014 - 06/2012
3	Small Interfering RNA (siRNA)IBA 01/2014 - 11/2010
2	Dendrimers (Dendrons)IBA 01/2023 - 01/2020
2	CytokinesIBA 01/2023 - 03/2017
2	Tricarboxylic AcidsIBA 12/2022 - 03/2022
2	Peptides (Polypeptides)IBA 11/2022 - 04/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2022 - 01/2010
2	Amyloid (Amyloid Fibrils)IBA 09/2022 - 04/2011
2	ZincIBA 09/2022 - 08/2003
2	CarbonIBA 03/2022 - 01/2020
2	HexosaminesIBA 03/2022 - 02/2021
2	pyrenedodecanoylcarnitineIBA 01/2022 - 12/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 01/2019

Therapy/Procedure

23	Therapeutics 01/2023 - 01/2009
20	Drug Therapy (Chemotherapy) 01/2021 - 09/2006
4	Oral Administration 01/2014 - 05/2003
3	Immunotherapy 01/2023 - 11/2019
2	Denervation 01/2022 - 01/2022